Oregon Public Employees Retirement Fund’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
PCM
LCM
FCM
ACM
CS
Oregon Public Employees Retirement Fund's BMY.RT Position: Q2 2020 in Review
Oregon Public Employees Retirement Fund sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q2 2020, closing a stake of 1,971 shares — an estimated $7K sold.
Oregon Public Employees Retirement Fund first reported a position in BMY.RT in Q4 2019 and held it in 2 quarters. The position peaked at $60K in Q4 2019. 583 funds tracked by Wall St. Rank hold BMY.RT as of Q2 2020.
- Oregon Public Employees Retirement Fund reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q2 2020 after selling out during the quarter.
- Oregon Public Employees Retirement Fund sold 1,971 Bristol-Myers Squibb Company Contingent Value Rights shares in Q2 2020, an estimated $7K.
- Oregon Public Employees Retirement Fund first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 2 quarters.
- Oregon Public Employees Retirement Fund's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $60K in Q4 2019.
- 583 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q2 2020.
Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2020, filed 21 Jul 2020.